A fresh wave of nicotine taxation is sweeping the United States, and it’s changing the game for smoke-free alternatives. And what started as a campaign to address plunging cigarette revenues has morphed into a broad push that would bring within the same tax framework smoke-free alternatives — especially nicotine pouches. For those who focus on tobacco harm reduction, the stakes are high: taxation is not just a revenue-generating mechanism but an instrument of policy that could help speed up or thwart smoking cessation.
Utah’s recent reforms help clarify this shift. Beginning July 1, 2026, the state will impose a new tax of 11 cents per cigarette, along with a new framework to govern nicotine pouches: $1 per can, with additional charges as the pouch count increases. This replaces older weight-based systems with a hybrid unit-and-volume tax. And updated definitions ensure that all nicotine products, including pouches and e-cigarettes, are explicitly covered in the tax code. On paper, this is modernization. In practice, it indicates a wider alignment: the fundamental products as if they present similar risks.
And Utah is far from alone. Other states, including New York, Michigan, Massachusetts, Vermont and Washington, are proposing or enacting similar measures across the country. Nicotine pouches in many instances are being taxed at the rates historically applied to cigarettes or other high-risk tobacco products. The reasoning is well known — youth uptake, concerns about addiction, funding for public health — but it often neglects an important aspect: relative risk.
Taxing safer alternatives like cigarettes
Why does this matter? Because nicotine pouches are not cigarettes. They don’t have tobacco leaf, don’t burn, and create no smoke. There is an increasing body of evidence to suggest they are far less harmful than smoking cigarettes and can have a meaningful role in cessation.” Research on contemporary oral nicotine products suggests they may assist smokers in transitioning away from combustible tobacco — especially in conjunction with behavioral support. Real-world data from Nordic countries provide additional support for this consideration; in these countries, the wide adoption of oral nicotine has been associated with dramatic buildups in smoking prevalence.
But U.S. fiscal policy seems headed in the other direction. The most high-profile example of taxation as deterrence probably comes from New York. The state is proposing a 75% wholesale tax on nicotine pouches, the same as traditional tobacco products. The measure is projected to raise billions in revenue, but it has drawn huge backlash. The majority of New Yorkers do not support this measure, maintaining that pairing smoke-free alternatives to smoking contravene the principles of harm reduction movement since it removes financial incentive to switch, with less than 50% supporting passage. Some policymakers have even questioned whether a public health strategy can be based on making safer products more expensive than combustible ones.
In Washington State, for example, a 95% excise tax has already gone into effect — nearly doubling the retail price of many nicotine products. Similar actions in Minnesota and Rhode Island highlight an unmistakable trend: With cigarette use falling, governments are widening their tax base to add new categories of nicotine. Just in 2025, dozens of legislative proposals sought to rein in nicotine pouches, a strong sign that the tide was turning against favorable treatment for all brands.
What are the repercussions?
Economic modeling and real-world evidence both suggest that excessive taxation of reduced-risk products may delay smoking cessation — or even reverse it.
But this method comes with a cost. Economic modeling and real-world evidence both suggest that excessive taxation of reduced-risk products may delay smoking cessation — or even reverse it. If the price gap between cigarettes and competitors narrows, so does the incentive to switch. Cost is still one of the most potent motivators for adult smokers seeking lower-risk alternatives.In Thailand, officials have adopted a far different — but equally aggressive — tack. Instead of taxation, enforcement has served as the main tool. The government has stepped up enforcement against sales and marketing of nicotine pouches, especially in tourist areas and on online marketplaces. These include fines and possible jail time, reflecting widespread concerns about youth use and unregulated sales. If couched as a public health intervention, such stringent enforcement could drive consumers into underground markets, where product quality and safety are far less assured.
Opposing such avenues, groups like the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) have long advocated another way. Instead of blanket taxation or prohibition, CAPHRA promotes risk-proportionate regulation: rigorous age controls, well-defined product standards, and clear labeling guidance, backed by policies that preserve accessibility for adult smokers. Their stance is bolstered by both scientific research and actual consumer experience from around the world, where harm reduction approaches are evidenced to work in reducing smoking rates.
Time to stop ignoring science and real-world evidence
This makes the current wave of U.S. tax hikes look increasingly out of step with global evidence. Nowhere is the contrast clearer than in Sweden, which just reached its lowest-ever smoking rates. Among adults, daily smoking prevalence has fallen to just 3.7%, fueled in large part by the widespread availability of oral nicotine products like snus, as well as nicotine pouches. Instead of demonizing these substitutes, Sweden has incorporated them into a harm-reduction paradigm — outcomes over ideology (but more on that in our next article.)
The result is not just fewer smokers, but vastly lower rates of smoking-related illness.
Given all this, taxing nicotine pouches the same way as cigarettes seems less like good policy and more like using a blunt tool. While it’s important to address youth access and product standards, these issues can be addressed through targeted regulations rather than broad taxes that may have unintended consequences.
Ultimately, the dispute boils down to a basic question: Does public health policy need to reflect relative risk? If we are trying to reduce smoking, the single largest preventable cause of death worldwide, then the answer should be clear. Policies that make safer alternatives less accessible, less affordable, or — not least — simply less enticing than cigarettes are not only counterproductive; they are, in the face of a mounting body of evidence, increasingly hard to justify. And as Sweden’s experience shows, there is an alternative.
